Neurorehabilitation in multiple sclerosis;Neurorrehabilitación en esclerosis múltiple

Neurologia

Volumn 20, Issue 5, 2005, Pages 245-254

  Sastre Garriga, J ^a   Galan Cartana I ^b   Montalban, X ^c   Thompson, Alan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Departamento de Fisioterapia   (Spain)

^c Unidad de Neuroinmunologia Clinica   (Spain)

Author keywords

Multiple sclerosis; Neuroplasticity; Neurorehabilitation; Physiotherapy

Indexed keywords

HEALTH EDUCATION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; QUALITY OF LIFE; REVIEW;

ADAPTATION, PSYCHOLOGICAL; BRAIN; HOLISTIC HEALTH; HUMANS; MULTIPLE SCLEROSIS; NEURONAL PLASTICITY;

EID: 22144457474     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Greenwood R. The future of rehabilitation lies in retraining, replacement, and regrowth. BMJ 2001;323:1082-3.
2. Ward CD, McIntosh S. The rehabilitation process: a neurological perspective. En: Greenwood RJ, Barnes MP, McMillan TM, Ward CD, editores. Handbook of neurological rehabilitation. New York: Psychology Press, 2003; p. 15-28.
3. Thompson AJ. Neurological rehabilitation: from mechanisms to management. J Neurol Neurosurg Psychiatry 2000;69:718-22.
4. McDonald WI, Compston DAS, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for MS. Ann Neurol 2001;50:121-7.
5. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-61.
6. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996; 39:285-94.
7. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 1998; 352:1498-504.
8. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. Neurology 1995;45:1268-76.
9. Rio J, Nos C, Tintore M, Borras C, Galán I, Comabella M, et al. Assessment of différent treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials. Ann Neurol 2002;52:400-6.
10. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, et al. Primary progressive multiple sclerosis. Brain 1997; 120:1085-96.
11. Kraft GH. Rehabilitation still the only way to improve function in multiple sclerosis. Lancet 1999;354:2016-7.
12. Barnes MP. Principles of neurological rehabilitation. J Neurol Neurosurg Psychiatry 2003;74(Suppl. IV):S3-S7.
13. Wade DT, de Jong BA. Recent advances in rehabilitation. BMJ 2000;320:1385-8.
14. World Health Organization. Towards a common language for functioning, disability and health. ICF. Geneva, 2002.
15. Organización Mundial de la Salud. Clasificación International del Funcionamiento (CIF). Introduccion. Ginebra, 2001.
16. Bliss W, Lomo T. Long-lasting potentiation of synaptic transmision in the dentate area of the anesthesized rabitt following stimulation of the perforant path. J Physiol 1973;232:331-56.
17. Turkstra LS, Holland AL, Bays GA. The neuroscience of recovery and rehabilitation: what have we learned from animal research? Arch Phys Med Rehabil 2003;84:604-12.
18. Bennet MR. The concept of long-term potentiation of transmision at synapses. Prog Neurobiol 2000;60:109-37.
19. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-7.
20. Eriksson PS. Neurogenesis and its implications for regeneration in the adult brain. J Rehabil Med 2003;41(Suppl.):17-9.
21. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 1999;2:203-5.
22. Hebb DO. The organization of behavior. A neuropsychological theory. New York: Wiley, 1949.
23. Mottaghy FM. TMS: using brain plasticity to treat chronic poststroke symptoms. Neurology 2003;61:881-82.
24. Uy J, Ridding MC, Hillier S, Thompson PD, Miles TS. Does induction of plastic change in motor cortex improve leg function after stroke? Neurology 2003;61:982-4.
25. Rushton DN. Functional electric stimulation and rehabilitation - an hypothesis. Med Eng Phys 2003;25:75-8.
26. Peurala SH, Pitkanen K, Sivenius J, Tarkka IM. Cutaneous electrical stimulation may enhance sensorimotor recovery in chronic stroke. Clin Rehabil 2002;16:709-16.
27. Nudo RJ. Adaptive plasticity in motor cortex: implications for rehabilitation after brain injury. J Rehabil Med 2003; 41(Suppl.): 7-10.
28. Nudo RJ, Wise BM, Sifuentes F, Milliken GW. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996;272:1791-4.
29. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci 1992;89:5675-9.
30. Werring DJ, Bullmore ET, Toosy AT, Miller DH, Barker GJ, MacManus DG, et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance study. J Neurol Neurosurg Psychiatry 2000;68:441-9.
31. Pantano P, Iannetti GD, Caramia F, Mainero C, Di Legge S, Bozzao L, et al. Cortical motor reorganization alter a single clinical attack of multiple sclerosis. Brain 2002;125:1607-15.
32. Rocca MA, Mezzapesa DM, Falini A, Ghezzi A, Martinelli V, Scotti G, et al. Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2003;18:847-55.
33. Rocca MA, Gavazzi C, Mezzapesa DM, Falini A, Colombo B, Mascalchi M, et al. A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis. Neuroimage 2003;19:1770-7.
34. Ciccarelli O, Toosy AT, Marsden JF, Ingle GT, Wheeler-Kingshott, Miller DH, et al. Functional brain reorganization for foot movement in patients with primary progressive multiple sclerosis. Mult Scler 2003;9:S15-6.
35. Filippi M, Rocca MA. Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging. Curr Opin Neurol 2003;16:275-82.
36. Ward NS, Brown MM, Thompson AJ, Frackowiack RSJ. Neural correlates of motor recovery after stroke: a longitudinal fMRI study. Brain 2003;126:2476-96.
37. Johansen-Berg H, Dawes H, Guy C, Smith SM, Wade DT, Matthews PM. Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain 2002; 125:2731-42.
38. Academy of Medical Sciences (2004) Putting Neurosciences to work in neurorehabilitation http://www.acmedsci.ac.uk/p_neurofunc.pdf [en la www]. Acceso: abril 2004.
39. Thompson AJ. The effectiveness of neurological rehabilitation in multiple sclerosis. J Rehab Research Development 2000;454-61.
40. Thompson AJ. Progress in neurorehabilitation in multiple sclerosis. Curr Opin Neurol 2002;15:267-70.
41. Hart WJ. It's more than a black box; it's a Russian doll: defining rehabilitation treatments. Am J Phys Med Rehabil 2003;82:639-52.
42. Giantomaso T, Makowsky L, Ashworth NL, Sankaran R. The validity of patient and physician estimates of walking distance. Clin Rehabil 2003;17:394-401.
43. Hoogervorst ELJ, van Winsen LML, Eikelenboom MJ, Kalkers NF, Uitdehaag BMJ, Polman CH. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology 2001;56:934-7.
44. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580.
45. Edwards SGM, Playford ED, Hobart JC, Thompson AJ. Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation. BMJ 2002;324:1493.
46. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure. Brain 2001;124:962-73.
47. Sastre-Garriga J, Velázquez M, Porcel J, Thompson AJ, Montalbán X, Hobart J. Adaptación al español del Multiple Sclerosis Impact Scale-29 (MSIS-29). Neurología 2003;9:572.
48. Cardol M, de Haan RJ, van den Bos GAM, de Jong Ba, de Grot IJM. The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil 1999; 13:411-9.
49. Vazirinejad R, Lilley JM, Ward CD. The «Impact on Participation and autonomy»: acceptability of the english version in a multiple sclerosis outpatient setting. Mult Scler 2003;9:612-5.
50. Feigenson JS, Scheinberg L, Catalano M, Polkow L, Mantegazza PM, Feigenson WD, et al. The cost-effectiveness of multiple sclerosis rehabilitation: a model. Neurology 1981;31:1316-22.
51. Greenspun B, Stineman M, Agri R. Multiple sclerosis and rehabilitation outcome. Arch Phys Med Rehabil 1987;68:434-7.
52. Reding MJ, LaRocca NG, Madonna M. Acute hospital care versus rehabilitation hospitalisation for management of nonemergent complications in multiple sclerosis. J Neurol Rehabil 1987;1:13-7.
53. Carey RG, Seibert JH, Posavac EJ. Who makes the most progress in inpatient rehabilitation? An analysis of functional gain. Arch Phys Med Rehabil 1988;69:337-43.
54. Kidd D, Howard NA1 Losseff N, Thompson AJ. The benefit of inpatient neurorehabilitation in multiple sclerosis. Clin Rehabil 1995;9:198-203.
55. Aisen ML, Sevilla D, Fox N. Inpatient rehabilitation for multiple sclerosis. J Neurol Rehabil 1996;10:43-6.
56. Kidd D, Thompson AJ. Prospective study of neurorehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:423-4.
57. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997;42:236-44.
58. DiFabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT. Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998;79:141-6.
59. Freeman JA, Langdon DW, Hobart JC1 Thompson AJ. Inpatient rehabilitation in multiple sclerosis. Do the benefits carry over into the community? Neurology 1999;52:50-6.
60. Craig J, Young CA, Ennis M, Baker G, Boggild M. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid therapy. J Neurol Neurosurg Psychiatry 2003;74:1225-30.
61. Liu C, Playford ED, Thompson AJ. Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 2003; 250:1214-8.
62. Pozzilli C, Brunetti M, Amicosante AMV, Gasperini C, Ristori G, Palmesano L, et al. Home based management in multiple sclerosis: a result of a randomised controlled trial. J Neurol Neurosurg Psychiatry 2002;73:250-5.
63. Francabandera FL, Holland NJ, Wiesel-Levison P, Scheinberg LC. Multiple sclerosis rehabilitation: inpatient vs outpatient. Rehabil Nurs 1988;13:251-3.
64. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:174-9.
65. Fuller KJ, Dawson K, Wiles CM. Physiotherapy in chronic multiple sclerosis: a controlled trial. Clin Rehabil 1996;10:195-204.
66. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39:432-41.
67. Lord SE, Wade DT, Halligan PW. A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study. Clin Rehabil 1998; 12:477-86.
68. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, LaMantia L, et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999;52:57-62.
69. Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 2002;8:161-8.
70. Steultjens EMJ, Dekker J, Bouter LM, Cardol M, Van de Nes JCM, Van den Ende CHM. Occupational therapy for multiple sclerosis (Cochrane Review). En: The Cochrane Library, Issue 1. Chichester, UK: John Wiley and Sons, Ltd, 2004.
71. Freeman JA, Hobart JC, Thompson AJ. Outcomes-based research in neurorehabilitation: the need for multidisciplinary team involvement. Disabil Rehabil 1996;18:106-10.
72. Thompson AJ. Symptomatic management and rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;71 (Suppl. 2): S22-7.
73. Wade DT. Clinical governance and rehabilitation services. Clin Rehabil 2000;14:1-4.
74. Johnson J, Thompson AJ. Rehabilitation in a neuroscience centre: the role of expert assessment and selection. BJTR 1996; 3:303-8.
75. Wade DT. Evidence relating to assessment in rehabilitation. Clin Rehabil 1998;12:183-6.
76. Mott S. Rehabilitation and the importance of partnerships. IJTR 2003;10:142.
77. Lincoln NB, Dent A, Harding J, Weyman N, Nicholl C, Blumhardt LD, et al. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:93-8.
78. Wade DT. Cognitive assessment and neurological rehabilitation. Clin Rehabil 2002;16:117-8.
79. Wade DT. Evidence relating to goal planning in rehabilitation. Clin Rehabil 1998;12:273-5.
80. Sivaraman KP, Wade DT. Life goals of people with disabilities due to neurological disorders. Clin Rehabil 2003;17:521-7.
81. Playford ED, Dawson L, Limbert V, Smith M, Ward CD, Wells R. Goal-setting in rehabilitation: report of a workshop to explore professionals' perceptions of goal-setting. Clin Rehabil 2000; 14:491-6.
82. Rossiter D, Thompson AJ. Introduction of integrated care pathways for patients with multiple sclerosis in an inpatient neurorehabilitation setting. Disabil Rehabil 1995;17:443-8.
83. Rossiter DA, Edmondson A, Al-Shahi R, Thompson AJ. Integrated care pathways in multiple sclerosis rehabilitation: completing the audit cycle. Mult Scler 1998;4:85-9.
84. Molina Martínez FJ, Calles Hernández MC, García Martín A, Sureda Ramis B. Vías clinicas: fundamentos, descripción y posibles aplicaciones en neurología. Neurología 2003;18: 439-51.
85. McKeown LP, Porter-Armstrong AP, Baxter GD. The needs and experiences of caregivers of individuals with multiple sclerosis: a systematic review. Clin Rehabil 2003;17:234-48.
86. Martínez Yelamos S, Martínez Yelamos A, Hernández Regadera JJ, Martín Ozaeta G, Arbizu Urdiain T. The social and work-related impact of multiple sclerosis. Neurologia 1999;14: 107-10.
87. Paisley S, Beard S, Hunn A, Wight J. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review. Mult Scler 2002;8:319-29.
88. Jarrett L, Leary SM, Porter B, Richardson D, Rosso T, Powell M, et al. Managing spasticity in people with multiple sclerosis. A goal-oriented approach to intrathecal baclofen therapy. Int J MS Care 2001;3:10-21.
89. Jarrett L, Nandi P, Thompson AJ. Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? J Neurol Neurosurg Psychiatry 2002;73:705-9.
90. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 2003;9:219-27.
91. Wishart HA, Roberts DW, Roth RM, McDonald BC, Coffey DJ, Mamourian AC, et al. Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports. J Neurol Neurosurg Psychiatry 2003;74:1392-7.
92. DasGupta R, Fowler CJ. Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol 2002;15:271-8.
93. Ward CD, Phillips M, Smith A, Moran M. Multidisciplinary approaches in progressive neurological disease: can we do better? J Neurol Neurosurg Psychiatry 2003;74(Suppl. 4):8-12.
94. Freeman JA, Thompson AJ. Community services in multiple sclerosis: still a matter of chance. J Neurol Neurosurg Psychiatry 2000;69:728-32.